Pain Interference Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab vs Zoledronic Acid (ZA) in Patients with Solid Tumors and Bone Metastases

Annals of Oncology ◽

10.1016/s0923-7534(20)34126-0 ◽

2012 ◽

Vol 23 ◽

pp. ix509-ix510

Author(s):

C. Cleeland ◽

L. Fallowfield ◽

R. von Moos ◽

D. Patrick ◽

D.H. Henry ◽

...

Keyword(s):

Clinical Trial ◽

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumors ◽

Pain Interference ◽

Download Full-text

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

Bone ◽

10.1016/j.bone.2010.01.098 ◽

2010 ◽

Vol 46 ◽

pp. S44

Author(s):

Roger von Moos ◽

David Henry ◽

Saroj Vadhan-Raj ◽

Vania Hungria ◽

Andrew Spencer ◽

...

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumors ◽

Advanced Solid Tumors ◽

Phase 3 ◽

Download Full-text

7004 ORAL Pain Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab Vs Zoledronic Acid (ZA) in Patients With Solid Tumours and Bone Metastases

European Journal of Cancer ◽

10.1016/s0959-8049(11)71955-4 ◽

2011 ◽

Vol 47 ◽

pp. S485

Author(s):

L. Fallowfield ◽

R. von Moos ◽

D. Patrick ◽

C.S. Cleeland ◽

D.H. Henry ◽

...

Keyword(s):

Clinical Trial ◽

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumours ◽

Phase 3 ◽

Oral Pain ◽

Download Full-text

Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases

10.1158/0008-5472.sabcs10-p1-13-01 ◽

2010 ◽

Author(s):

CS Cleeland ◽

DL Patrick ◽

L Fallowfield ◽

M Clemons ◽

A Lipton ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Pain Interference ◽

Daily Functioning ◽

Download Full-text

Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors

Seminars in Oncology ◽

10.1053/sonc.2002.37416 ◽

2002 ◽

Vol 29 (6 Suppl 21) ◽

pp. 28-32 ◽

Author(s):

Lee S. Rosen

Keyword(s):

Lung Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumors ◽

Efficacy And Safety

Download Full-text

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

Bone ◽

10.1016/j.bone.2010.01.078 ◽

2010 ◽

Vol 46 ◽

pp. S36-S37 ◽

Author(s):

Jean-Jacques Body ◽

Alison Stopeck ◽

Yasuhiro Fujiwara ◽

Allan Lipton ◽

Guenther Steger ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Phase 3 ◽

Download Full-text

P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.

10.1158/0008-5472.sabcs11-p3-16-07 ◽

2011 ◽

Author(s):

AT Stopeck ◽

A Lipton ◽

M Martin ◽

J-J Body ◽

A Paterson ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Metastases ◽

Treatment Phase ◽

Phase 3 ◽

Pivotal Phase ◽

Open Label Extension ◽

Previously Treated

Download Full-text

PCN132 MODELING THE LIFETIME EFFECTIVENESS OF DENOSUMAB AND ZOLEDRONIC ACID (ZA) IN THE PREVENTION OF SKELETAL RELATED EVENTS (SRE) IN PATIENTS WITH BONE METASTASES FROM SOLID TUMORS

Value in Health ◽

10.1016/j.jval.2011.02.986 ◽

2011 ◽

Vol 14 (3) ◽

pp. A179

Author(s):

M.D. Danese ◽

A. Bracco ◽

D. Macarios ◽

K. Chung ◽

A. Barlev ◽

...

Keyword(s):

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumors ◽

Skeletal Related Events

Download Full-text

A prospective randomized controlled clinical trial of zoledronic acid for bone metastases

American Journal of Hospice and Palliative Medicine® ◽

10.1177/104990910602300107 ◽

2006 ◽

Vol 23 (1) ◽

pp. 41-50 ◽

Author(s):

Kyriaki Mystakidou ◽

Emmanuela Katsouda ◽

Efi Parpa ◽

Evangelia Kouskouni ◽

Costas Chondros ◽

...

Keyword(s):

Clinical Trial ◽

Zoledronic Acid ◽

Bone Metastases ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Randomized Controlled

Download Full-text

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Journal of Medical Economics ◽

10.3111/13696998.2012.675380 ◽

2012 ◽

Vol 15 (4) ◽

pp. 712-723 ◽

Author(s):

Alison Stopeck ◽

Michael Rader ◽

David Henry ◽

Mark Danese ◽

Marc Halperin ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

Zoledronic Acid ◽

Bone Metastases ◽

Solid Tumors ◽

The United States ◽

Skeletal Related Events

Download Full-text

PCN146 HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

Value in Health ◽

10.1016/s1098-3015(11)72040-x ◽

2010 ◽

Vol 13 (7) ◽

pp. A279 ◽

Author(s):

JJ Body ◽

R von Moos ◽

A Stopeck ◽

Y Qian ◽

A Braun

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Advanced Breast Cancer ◽

Bone Metastases ◽

Cancer Patients ◽

Resource Utilization ◽

Health Resource ◽

Breast Cancer Patients ◽

Health Resource Utilization ◽

Download Full-text